Bicycle Therapeutics plc (NASDAQ:BCYC) Receives $25.00 Consensus Price Target from Analysts
Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) has been given an average rating of “Moderate Buy” by the ten research firms that are presently covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 […]
Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) has been given an average rating of “Moderate Buy” by the ten research firms that are presently covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 […]
